Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

NCT01231802 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Eniluracil
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Capecitabine

Sponsor

Adherex Technologies, Inc.